Format
Items per page
Sort by

Send to:

Choose Destination

Links from

Items: 1 to 20 of 82

1.

Automated patient-tailored screening of the liver for diffuse steatosis and iron overload using MRI.

Bashir MR, Zhong X, Dale BM, Gupta RT, Boll DT, Merkle EM.

AJR Am J Roentgenol. 2013 Sep;201(3):583-8. doi: 10.2214/AJR.12.10051.

PMID:
23971450
2.
3.

Automated two-point dixon screening for the evaluation of hepatic steatosis and siderosis: comparison with R2-relaxometry and chemical shift-based sequences.

Henninger B, Zoller H, Rauch S, Schocke M, Kannengiesser S, Zhong X, Reiter G, Jaschke W, Kremser C.

Eur Radiol. 2015 May;25(5):1356-65. doi: 10.1007/s00330-014-3528-8. Epub 2014 Dec 14.

PMID:
25501270
4.

Quantification of hepatic iron deposition in patients with liver disease: comparison of chemical shift imaging with single-echo T2*-weighted imaging.

Lim RP, Tuvia K, Hajdu CH, Losada M, Gupta R, Parikh T, Babb JS, Taouli B.

AJR Am J Roentgenol. 2010 May;194(5):1288-95. doi: 10.2214/AJR.09.3036.

PMID:
20410416
5.

Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination.

Bashir MR, Merkle EM, Smith AD, Boll DT.

Eur J Radiol. 2012 Feb;81(2):e101-9. doi: 10.1016/j.ejrad.2011.01.067. Epub 2011 Feb 16.

PMID:
21330083
6.

Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload.

Henninger B, Kremser C, Rauch S, Eder R, Zoller H, Finkenstedt A, Michaely HJ, Schocke M.

Eur Radiol. 2012 Nov;22(11):2478-86. doi: 10.1007/s00330-012-2506-2. Epub 2012 May 30.

PMID:
22645044
7.

MRI: the new reference standard in quantifying hepatic steatosis?

Raptis DA, Fischer MA, Graf R, Nanz D, Weber A, Moritz W, Tian Y, Oberkofler CE, Clavien PA.

Gut. 2012 Jan;61(1):117-27. doi: 10.1136/gutjnl-2011-300155. Epub 2011 Oct 13.

PMID:
21997548
8.

Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence.

Chandarana H, Lim RP, Jensen JH, Hajdu CH, Losada M, Babb JS, Huffman S, Taouli B.

AJR Am J Roentgenol. 2009 Nov;193(5):1261-7. doi: 10.2214/AJR.08.1996.

PMID:
19843739
9.

Automated liver sampling using a gradient dual-echo Dixon-based technique.

Bashir MR, Dale BM, Merkle EM, Boll DT.

Magn Reson Med. 2012 May;67(5):1469-77. doi: 10.1002/mrm.23123. Epub 2011 Aug 16.

PMID:
22190284
10.

Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse.

Hines CD, Agni R, Roen C, Rowland I, Hernando D, Bultman E, Horng D, Yu H, Shimakawa A, Brittain JH, Reeder SB.

J Magn Reson Imaging. 2012 Apr;35(4):844-51. doi: 10.1002/jmri.22890. Epub 2011 Nov 29.

11.

MR imaging of diffuse liver disease. Hepatic fat and iron.

Siegelman ES.

Magn Reson Imaging Clin N Am. 1997 May;5(2):347-65. Review.

PMID:
9113679
12.

Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.

Kang BK, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee MG.

Invest Radiol. 2012 Jun;47(6):368-75. doi: 10.1097/RLI.0b013e31824baff3.

PMID:
22543969
13.

Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.

Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, Suh DJ, Kim KM, Bae MH, Lee JY, Lee SG, Yu ES.

J Hepatol. 2010 Apr;52(4):579-85. doi: 10.1016/j.jhep.2010.01.008. Epub 2010 Feb 2.

PMID:
20185194
14.

Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation.

Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, Abecassis M, Blei AT.

Liver Transpl. 2003 Aug;9(8):851-6. Erratum in: Liver Transpl. 2003 Nov;9(11):1230.

15.

Noninvasive liver steatosis quantification using MRI techniques combined with blood markers.

Cesbron-Métivier E, Roullier V, Boursier J, Cavaro-Ménard C, Lebigot J, Michalak S, Calès P, Aubé C.

Eur J Gastroenterol Hepatol. 2010 Aug;22(8):973-82.

PMID:
20665947
16.

Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.

Mennesson N, Dumortier J, Hervieu V, Milot L, Guillaud O, Scoazec JY, Pilleul F.

J Comput Assist Tomogr. 2009 Sep-Oct;33(5):672-7. doi: 10.1097/RCT.0b013e318199d883.

PMID:
19820490
17.

Overload hepatitides: quanti-qualitative analysis.

Martí-Bonmatí L, Alberich-Bayarri A, Sánchez-González J.

Abdom Imaging. 2012 Apr;37(2):180-7. doi: 10.1007/s00261-011-9762-5. Review.

PMID:
21643735
18.

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, Volp A, Horsfall L, Jothimani D, Fawcett J, Galloway GJ, Benson M, Powell EE.

J Hepatol. 2009 Aug;51(2):389-97. doi: 10.1016/j.jhep.2009.04.012. Epub 2009 May 18.

PMID:
19505740
19.

Abdominal lymphadenopathy in beta-thalassemia: MRI features and correlation with liver iron overload and posttransfusion chronic hepatitis C.

Papakonstantinou O, Maris TG, Kostaridou S, Ladis V, Vasiliadou A, Gourtsoyiannis NC.

AJR Am J Roentgenol. 2005 Jul;185(1):219-24.

PMID:
15972427
20.

An online open-source tool for automated quantification of liver and myocardial iron concentrations by T2* magnetic resonance imaging.

Git KA, Fioravante LA, Fernandes JL.

Br J Radiol. 2015 Sep;88(1053):20150269. doi: 10.1259/bjr.20150269. Epub 2015 Jun 29.

PMID:
26118302
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk